Carcinoma of Unknown Primary — Trials

Carcinoma of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,232 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,156
Recruiting: 2,259
Ph III recruiting: 269
Growth YoY: +12.3%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,893)

clinicaltrialsPublishedShowing 701–750 of 1,200 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06895031	Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS(STAR)	recruiting	Phase 2	210	Guangzhou JOYO Pharma Co., LtdINDUSTRY	1	Mar 6, 2026	clinicaltrials
NCT05068232	Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)	recruiting	Phase 2	49	University of ChicagoOTHER	1	Mar 4, 2026	clinicaltrials